"For the subgroup analyses on slide 19 for above and below LDL-C and HbA1c, is this based on baseline values at start of study or values at end of study
Similar question for the eGFR<60 vs. eGFR>60. eGFR at baseline or end of study?"
Beginning of study. Testing hypotheses that certain groups (of presumably sicker) patients at the start of the trial will benefit more from the drug.
Agree that the LDL result is puzzling.
Jupe